Researchers at Rutgers University are investigating a potential treatment for people recently diagnosed with SARS-CoV-2 who have no or mild symptoms. The trial — called Triple Combination Antiviral Coronavirus Therapy (TriACT) — seeks to determine whether treating asymptomatic or mildly symptomatic people with a combination of nitazoxanide, ribavirin and hydroxychloroquine will reduce the amount of virus and the chance […]
Rutgers Leading Clinical Trial on 3-Drug Combination Treatment for COVID-19
Dec08,2020
By 